RadioPharm Theranostics CEO Presentation March 2022

Loading viewer...

investor_presentation

Format: PDF investor_presentation

RadioPharm Theranostics Ltd CEO presentation delivered in March 2022, covering corporate profile and strategic updates. The biotech company, listed on ASX under ticker RAD since November 2021, focuses on radiopharmaceutical theranostics development with clinical trial programs underway.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

Similar investor_presentations from other companies

Browse all →

investor_presentation

Evolus

Investor Presentation February March 2017

investor_presentation